Just a quick summary after going through all the latest NR´s as part of my DD.
So the way I understand it we can expect further feedback on the following (of what we know is going on) in the near future:
-R327 for burn treatment: ongoing trial
-R327 for sepsis: ongoing trial
-R327/R529 against Covid; update expected anytime?! Any infos given in AGM?
-R435 studies against H. pylori
-R327/R111 studies against bacterial sinusitis
What we know:
-R327 works against ESKAPE pathogens
-R327 works on flesh eating bacteria
-R327 MoA has been identified and presented at conferences
-R327 works in general against numerous antibiotic resistant bacteria
Did I leave anything out? Looks really promising, with a packed pipeline!
Recap of ongoing studies / tests
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
0.005(0.76%) |
Mkt cap ! $135.6M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.5¢ | 65.0¢ | $59.11K | 89.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4602 | 66.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 17411 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
66.5¢ |
Change
0.005 ( 1.45 %) |
||||
| Open | High | Low | Volume | ||
| 65.0¢ | 66.5¢ | 65.0¢ | 25878 | ||
| Last updated 14.06pm 07/05/2024 ? | |||||
| RCE (ASX) Chart |